Geron | GERN - Les Charges D'Exploitation

Prix De L'Action
1.60
Variation Quotidienne
-0.05 -3.03%
Mensuellement
-8.05%
Annuel
22.14%
Q2 Prévisions
1.55




Les Charges D'Exploitation Changement Date
Amgen USD 4.78B 1.12B 2026-03
Bio Techne USD 241.42M 2.52M 2025-12
Cassava Sciences USD 13.55M 1.69M 2025-12
Cytokinetics USD 200.58M 4.46M 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 359.47M 3.28M 2026-03
Genmab DKK 798M 235M 2025-12
Geron USD 58.8M 2.31M 2025-12
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 5.62B 4.5B 2026-03
MacroGenics USD 53.32M 13.68M 2025-12
Novartis USD 9.29B 507M 2026-03
Novavax USD 126.2M 23.62M 2025-12